Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-23
2007-10-23
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S231200, C514S364000, C514S317000, C544S098000, C546S226000, C546S207000, C548S240000, C548S215000, C564S050000
Reexamination Certificate
active
11135499
ABSTRACT:
Novel biaromatic compounds having the structural formula (I) below:are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
REFERENCES:
patent: 6908939 (2005-06-01), Bernardon et al.
patent: 2006/0148862 (2006-07-01), Clary et al.
Bouix-Peter Claire
Clary Laurence
Collette Pascal
Jomard Andre
Rivier Michel
Anderson Rebecca
Buchanan & Ingersoll & Rooney PC
Chu Yong
Galderma Research & Development
LandOfFree
Biaromatic compounds which activate PPARgamma type receptors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biaromatic compounds which activate PPARgamma type receptors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biaromatic compounds which activate PPARgamma type receptors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3837713